immunoglobulin

partnership collaboration legal document
Biotech

CSL inks $328M Memo deal for option on antibody engineering tech

The deal allows CSL to potentially exercise an option that would give Memo up to $328 million on sales milestones.
Zoey Becker Feb 9, 2026 2:00am
MA strategy deal block push come together form

UK's Epsilogen acquires fellow immunoglobin biotech TigaTx

Apr 7, 2025 8:49am
pSivida

Bluejay Dx, Hitachi team up on noninvasive conjunctivitis test

Feb 27, 2017 11:18am